Nasdaq

Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications ...
Nasdaq

Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery

EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and ...
KRON4 News

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody ...

EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & ...
News Medical

Berkeley Lights launches Beacon Select™, a new optofluidic system for cell line development

Berkeley Lights, Inc., a life sciences tools company, today announced the launch of the Beacon Select ™, the company's new optofluidic system for cell line development (CLD). The Beacon Select builds ...